Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Weinstein

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
BMC Immunology|May 21, 2010
Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia VirusRaymond S Weinstein, Michael M Weinstein, Kenneth Alibek, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Mice expressing mutant Trpv4 recapitulate the human TRPV4 disordersMichael M Weinstein, Stuart W Tompson, Yuqing Chen, et al.
American Journal of Medical Genetics. Part A|August 18, 2016
Somatic mosaicism for a lethal TRPV4 mutation results in non-lethal metatropic dysplasiaMichael M Weinstein, Taekyu Kang, Ralph S Lachman, et al.
The Journal of Biological Chemistry|September 4, 2009
Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipaseAnne P Beigneux, Peter Gin, Brandon S J Davies, et al.
Current Opinion in Lipidology|July 11, 2007
GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicronsStephen G Young, Brandon S J Davies, Loren G Fong, et al.
Current Opinion in Lipidology|April 17, 2009
GPIHBP1 and lipolysis: an updateAnne P Beigneux, Michael M Weinstein, Brandon S J Davies, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1Xiao Shu, Lisa Nelbach, Michael M Weinstein, et al.
The Journal of Biological Chemistry|December 28, 2007
Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistanceLawrence W Castellani, Cara N Nguyen, Sarada Charugundla, et al.
Journal of Lipid Research|March 15, 2008
Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipaseAnne P Beigneux, Peter Gin, Brandon S J Davies, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 5, 2006
Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrowAngel Baldán, Liming Pei, Richard Lee, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
BMC Immunology|May 21, 2010
Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia VirusRaymond S Weinstein, Michael M Weinstein, Kenneth Alibek, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 20, 2014
Mice expressing mutant Trpv4 recapitulate the human TRPV4 disordersMichael M Weinstein, Stuart W Tompson, Yuqing Chen, et al.
American Journal of Medical Genetics. Part A|August 18, 2016
Somatic mosaicism for a lethal TRPV4 mutation results in non-lethal metatropic dysplasiaMichael M Weinstein, Taekyu Kang, Ralph S Lachman, et al.
The Journal of Biological Chemistry|September 4, 2009
Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipaseAnne P Beigneux, Peter Gin, Brandon S J Davies, et al.
Current Opinion in Lipidology|July 11, 2007
GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicronsStephen G Young, Brandon S J Davies, Loren G Fong, et al.
Current Opinion in Lipidology|April 17, 2009
GPIHBP1 and lipolysis: an updateAnne P Beigneux, Michael M Weinstein, Brandon S J Davies, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 23, 2010
Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1Xiao Shu, Lisa Nelbach, Michael M Weinstein, et al.
The Journal of Biological Chemistry|December 28, 2007
Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistanceLawrence W Castellani, Cara N Nguyen, Sarada Charugundla, et al.
Journal of Lipid Research|March 15, 2008
Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipaseAnne P Beigneux, Peter Gin, Brandon S J Davies, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 5, 2006
Impaired development of atherosclerosis in hyperlipidemic Ldlr-/- and ApoE-/- mice transplanted with Abcg1-/- bone marrowAngel Baldán, Liming Pei, Richard Lee, et al.
Pageof 3